Egészségügy | Betegségek » Merck Capacity Advancement Program CAP in India

Source: http://www.doksinet Source: http://www.doksinet Merck Supports Diabetes Medical Education and Community Awareness as part of its Capacity Advancement Program in India From Africa to India, Merck In the process of Implementing Its Capacity Advancement Program In Maharashtra state. medical and pharmacy undergraduates, physicians and pharmacists in rural areas. The 5 year program was kicked off successfully in 7 sub- Saharan countries which are Kenya, Uganda, Namibia Angola, Ghana, Tanzania and Mozambique and will further expand to other Sub-Saharan and Asian countries in 2014 Jetendra Awad , Minister of Medical Education and research, Rasha Kelej Vice President Of Business Responsibility and Market Development Meck serono Mumbai, August 25, 2014, after the huge success of Merck Capacity Advancement Program in Africa, Merck in collaboration with Ministry of Medical Education and Research, Government of Maharashtra has pledged to support diabetes education as part of its

capacity advancement program in the state. The Merck Capacity Advancement Program aims at expanding the professional capacity in the areas of research and development, clinical research, supply chain integrity and efficiency, pharmacovigilance, community awareness and medical education for Based on its long experience in diabetes management, which began in 1957 with the development of metformin, Merck seeks to raise awareness of diabetes in Africa by educating the public and supporting the healthcare system to prevent, diagnose and manage the condition effectively. As part of the Merck Capacity Advancement Program, more than 3,000 medical students from the 18 medical colleges of Maharashtra University of Health sciences will benefit from European-accredited clinical diabetes and chronic diseases management training, which is seeking to equip them with skills to avert the diabetes epidemic. Merck is planning to target more than 12,000 students by the end of 2018 expanding to more

sub-Saharan and Asian countries. Source: http://www.doksinet “We are especially delighted to partner with Merck to implement their Capacity Advancement Program in India. We welcome initiatives of this kind in our country and look forward to its success to help medical students, healthcare providers and the public in order to improve access to safe and high quality health care solutions across India” Jitendra Awad, Minister of Medical Education and Research, Maharashtra, India The rising numbers of diabetics all over the world calls for prioritizing diabetes care and awareness to prevent the disease from turning into an epidemic. The Merck Capacity Advancement Program seeks to improve the healthcare sector in India with special focus on rural areas, through educating and empowering those affected by diabetes on how to manage and prevent it. Maharashtra Government to change medical education policies and syllabus to focus on Diabetes and NonCommunicable Diseases, with the

support of Merck Capacity Advancement Program Mumbai, September 24, 2014 – Merck in collaboration with Maharashtra University of Health Sciences and Directorate of Medical Education & Research is introducing Merck Capacity Advancement Program (CAP) in Diabetes Education for medical undergraduates of 18 medical colleges in Maharashtra. The 5 year program will provide Clinical Diabetes Management course at all Governmental Medical Colleges in Maharashtra. The course is European accredited and will be incorporated in the MBBS curricula of 18 medical colleges. It is aimed to build up the future Diabetes health care capacity in Maharashtra Source: http://www.doksinet Dr Manisha Mhaiskar, Medical Education and Drug Department secretary, Maharashtra Government, welcomed Merck by stating: “We are happy to partner with Merck, to implement Merck’s Capacity Advancement Program in Maharashtra. This program is powerful, effective and well suited to the Indian audience with the

purpose of improving medical research, health education and clinical practice and hence improving the quality of life of people who live with diabetes in India.” Dr Manisha Mahiskar, Secretary of Medical education and research, MahrashstraGovernment, Dr. Arun Jamkar, Vice Chancellor , Mahrashstra University, Dr. Mansining Pawar, Director of Medical Education and Research, Prof. Shashank Joshi, President of Assocition of India, Rasha Kelej, Vice President , Merck Serono Dr Manisha Mhaiskar, medical education and drug department secretary, Maharashtra Government, agreed with Merck that a change in medical undergraduates’ syllabus and medical education policies and the implementation of Diabetes community out- reach programs are needed urgently to keep base with the changes of the emerging diseases such as diabetes and NCDs. Source: http://www.doksinet During the event, Prof. Dr Arun Jamkar, Vice Chancellor of Maharashtra University of Health Sciences emphasized: “It gives us

immense pleasure to invite the stakeholders in the field of medicine and diabetes in Maharashtra In joint collaboration with DMER and Merck, this Diabetes education course aims to provide guidelines and clinical practice for prevention, diagnosis and management of diabetes and its complications for medical undergraduates of the 18 medical colleges in Maharashtra University.” Merck seeks to raise awareness of diabetes in India by educating the public and supporting the healthcare system to prevent, diagnose and manage the condition effectively. As part of the Merck Capacity Advancement Program, by end of 2015, more than 3,000 medical students from the Maharashtra University of Health Sciences will benefit from Europeanaccredited clinical diabetes and chronic Prof. Shashank Joshi, The president of Association of Physicians of India- API welcomed the program “We are happy with our partnership with Merck to implement this program to support future diabetes health care in India.

Diabetes mellitus is reaching potentially epidemic proportions in India. The level of morbidity and mortality due to diabetes and its potential complications are enormous, and pose significant healthcare burdens on both families and society. Indians and Maharashtrians are uniquely predisposed to diabetes. There is an urgent need to develop teaching programs for health care providers so that diabetics dont need to go to specialists but basic management can be done by health care providers.” diseases management training, which is seeking to equip them with skills to avert the diabetes epidemic. Merck is planning to target more than 12,000 students by the end of 2018 expanding to more African and Asian countries. Meeting of Deans and Head of medical departments in 18 medical colleges of Maharashtra university The Course will be run in partnership of Merck and EXCEMED (Excellence in Medical Education) a leading global Medical Education Provider ------------------------------- Source:

http://www.doksinet On the Occasion of World Heart Day, Maharashtra Govt. in collaboration with Merck took a big step to help everyone in society by planning the “Diabetes Community Outreach Program”, for the upcoming World Diabetes Day. During the kickoff event Rasha Kelej, Vice President, Head of Global Business Responsibility and Market Development explained: “We are pleased to kickoff Merck Capacity Advancement Program (CAP) in India on the occasion of World Heart Day. There is a clear-cut relationship between diabetes and cardiovascular disease and the best way to prevent or delay the development of cardiovascular disease is to prevent diabetes itself. Therefore the program will address both diabetes and hypertension as part of our commitment to contributing to the social and economic development of India and the rest of the Asian continent. The socio- economic burden of the disease can be reduced by timely intervention from trained healthcare professionals, as many

patients can be prevented from developing diabetes if diagnosed at early stage” Merck Capacity Advancement Program in partnership with Ministry of Health and Maharashtra University will conduct Community Outreach Programs for diabetes awareness and prevention in each city that the 18 medical colleges are located in Maharashtra state. The program will be executed by medical postgraduates, nurses and diabetes educators, Merck has successfully conducted several diabetes awareness and prevention campaigns in Africa with special focus on rural areas and we will capitalize on our experience to ensure the success of Community Outreach Program of the medical colleges in India. The community outreach program will be conducted on the world diabetes day, 14th of November 2014. It is expected to address Source: http://www.doksinet more than 4000 community members across the state. In addition to medical education and community awareness, Merck will continue to work with partners in India

at large, to expand the capacity of public health in diabetes management through its Capacity Advancement Program. Healthcare Sector not only in Maharashtra state but also throughout India. The CAP will provide critical education and empowerment for those affected and dealing with diabetes to show the way to manage and prevent it. “ Dr. Stefan Oschmann, Member of the Executive Board Merck and CEO Pharma said “Merck is pleased to collaborate with Maharashtra University of Health Sciences and Directorate of Medical Education & Research as part of our commitment to building healthcare capacity and providing sustainable access to high-quality health solutions and safe medicines in India. Through you – Health leaders, faculty members and students, this program will seek to improve the Dr Stefan Oschmann , Merck Pharma CEO discussing Africa healthcare and medical education needs with faculty members of African Universities Merck CAP Africa 2014 Overview The Merck Africa

University CME Tour , run in partnership with EXCEMED and Oxford Centre of Diabetes, Source: http://www.doksinet Churchill Hospital, Oxford, UK and will reach general practitioners and medical & pharmacy students and pharmacists across Angola, Ghana, Kenya, Mozambique, Namibia, Tanzania and Uganda. Merck European accredited Diabetes course has become a regular part in undergraduates’ curricula in 10 colleges of 8 universities in seven Sub- Saharan African countries The education offered to medical & pharmacy students and healthcare providers during the CME tour of Africa is aligned with the standards of the European Accreditation Council for Continuing Medical Education (EACCME). The workshops, tailored to local needs, presented evidence-based data and novel diabetes management approaches through interactive clinical case studies. Source: http://www.doksinet Merck E- Learning initiative aims to fight diabetes in Africa and Developing Countries. Moreover parallel

CME-accredited online course will be available on the www.managediabetesonlineorg website for pharmacy, medical students and HCPs unable to attend the live CME Tour events. Merck has also lunched the “Merck SMS Diabetes Awareness Campaign” targeting healthcare providers, medical students, patients and the general public across Uganda and Kenya with special focus on rural areas in partnership with Kenya and Uganda Ministries of Health, Makerere and Nairobi Universities and the Uganda Diabetes Association. Merck is in the process to develop Global Health Platform between Africa, Asia and Europe which will serve as an interactive platform for Merck Capacity Advancement Program (CAP) whose objective is to foster exchange of experiences and information between healthcare providers , faculty members and medical students. The interactions will be made possible through either life training courses or webbased technology and video conferencing where tele-education, training workshop and

medical education sessions will be offered. Through this e – health platform, Merck will bring developing and developed countries to together with an aim of achieving health impact. “Merck will provide European accredited “Clinical Diabetes Management” course to medical students in Maharashtra University in India, just like we did in Africa,” said Rasha kelej, Vice President, Head of Global Business Responsibility and Market Development Merck serono. The Merck Capacity Advancement Program will further be expanded to different developing countries in Sub-Saharan Africa, Asia, Latin America and Central Eastern Europe. Ms. Kelej explained that they will connect India to Africa as a part of Merck Global Health Platform strategy to share and exchange clinical experience and disease Source: http://www.doksinet awareness in areas such as diabetes, hypertension, thyroid dysfunction and Fertility management. Merck CAP in Africa is in partnership with Ministries of Health, African

Universities of Health Sciences, local research institution, medical and pharmaceutical association, patient association, community and media. Merck Africa and Asia Universities CME tour will enhance local awareness and build healthcare capacity in diabetes and chronic disease management by educating the students who will be the future HCPs in Africa so that they ultimately act as diabetes ambassadors. In addressing these challenges, Merck has shown consistent approach to their corporate social responsibility agenda in Africa since 2013. Merck, the German Pharmaceutical company plays a great role to build healthcare capacity in Africa and Asia with special focus on diabetes and chronic diseases. The Cabinet Secretary of the Ministry of Health Of Kenya James Macharia welcomed Merck stating: “Our ministry is especially delighted to partner with Merck, a company that is committed to Building healthcare capacity and providing sustainable access to high quality, safe medication and

health solutions in developing countries.” The Principal of the College of Health Sciences University of Nairobi, Prof. Isaac Kibwage emphasized that Nairobi University is happy to be part of a noble initiative such as Merck’s Capacity Advancement Program (CAP) and to associate with other institutions whose overall objectives and goals are directed towards alleviating challenges in the provision of healthcare, especially emerging diseases such as Diabetes. Source: http://www.doksinet The principal of health sciences, Prof. Nelson Sewankambo, said: “The partnership with Merck, the world’s oldest pharmaceutical and chemical company, to implement the Capacity Advancement Program in Uganda and to support chronic disease healthcare will help us to tackle the ever rising diabetes prevalence rate.” “It is clear that if not addressed as a matter of urgency, diabetes, will soon threaten the economic viability of Africa. And sadly, many people who survive HIV and AIDS may die of

diabetes" Rasha Kelej said Source: http://www.doksinet